vs
AFFILIATED MANAGERS GROUP, INC.（AMG）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
AFFILIATED MANAGERS GROUP, INC.の直近四半期売上が大きい（$556.6M vs $493.8M、Pediatrix Medical Group, Inc.の約1.1倍）。AFFILIATED MANAGERS GROUP, INC.の純利益率が高く（62.4% vs 6.8%、差は55.6%）。AFFILIATED MANAGERS GROUP, INC.の前年同期比売上増加率が高い（6.2% vs -1.7%）。過去8四半期でAFFILIATED MANAGERS GROUP, INC.の売上複合成長率が高い（5.5% vs -0.1%）
Affiliated Managers Group（略称AMG）は1993年に創業した米国の金融サービス会社で、本社はフロリダ州ウェストパームビーチに所在している。同社株はニューヨーク証券取引所に上場し、ティッカーコードはAMGで、S&P400米国中堅企業指数の構成銘柄の一つでもある。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
AMG vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $556.6M | $493.8M |
| 純利益 | $347.5M | $33.7M |
| 粗利率 | — | — |
| 営業利益率 | 94.4% | 9.9% |
| 純利益率 | 62.4% | 6.8% |
| 売上前年比 | 6.2% | -1.7% |
| 純利益前年比 | 114.2% | 10.5% |
| EPS（希薄化後） | $10.87 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $556.6M | $493.8M | ||
| Q3 25 | $528.0M | $492.9M | ||
| Q2 25 | $493.2M | $468.8M | ||
| Q1 25 | $496.6M | $458.4M | ||
| Q4 24 | $524.3M | $502.4M | ||
| Q3 24 | $516.4M | $511.2M | ||
| Q2 24 | $500.3M | $504.3M | ||
| Q1 24 | $499.9M | $495.1M |
| Q4 25 | $347.5M | $33.7M | ||
| Q3 25 | $212.4M | $71.7M | ||
| Q2 25 | $84.3M | $39.3M | ||
| Q1 25 | $72.4M | $20.7M | ||
| Q4 24 | $162.2M | $30.5M | ||
| Q3 24 | $123.6M | $19.4M | ||
| Q2 24 | $76.0M | $-153.0M | ||
| Q1 24 | $149.8M | $4.0M |
| Q4 25 | 94.4% | 9.9% | ||
| Q3 25 | 68.7% | 13.8% | ||
| Q2 25 | 34.8% | 12.8% | ||
| Q1 25 | 25.5% | 7.0% | ||
| Q4 24 | 52.2% | 7.8% | ||
| Q3 24 | 42.0% | 6.6% | ||
| Q2 24 | 35.6% | -31.3% | ||
| Q1 24 | 50.8% | 3.2% |
| Q4 25 | 62.4% | 6.8% | ||
| Q3 25 | 40.2% | 14.5% | ||
| Q2 25 | 17.1% | 8.4% | ||
| Q1 25 | 14.6% | 4.5% | ||
| Q4 24 | 30.9% | 6.1% | ||
| Q3 24 | 23.9% | 3.8% | ||
| Q2 24 | 15.2% | -30.3% | ||
| Q1 24 | 30.0% | 0.8% |
| Q4 25 | $10.87 | $0.40 | ||
| Q3 25 | $6.87 | $0.84 | ||
| Q2 25 | $2.80 | $0.46 | ||
| Q1 25 | $2.20 | $0.24 | ||
| Q4 24 | $4.95 | $0.37 | ||
| Q3 24 | $3.78 | $0.23 | ||
| Q2 24 | $2.26 | $-1.84 | ||
| Q1 24 | $4.14 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $586.0M | $375.2M |
| 総負債低いほど良い | $2.7B | $570.5M |
| 株主資本純資産 | $3.2B | $865.9M |
| 総資産 | $9.2B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.83× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $586.0M | $375.2M | ||
| Q3 25 | $476.1M | $340.1M | ||
| Q2 25 | $361.0M | $224.7M | ||
| Q1 25 | $816.5M | $99.0M | ||
| Q4 24 | $950.0M | $229.9M | ||
| Q3 24 | $1.0B | $103.8M | ||
| Q2 24 | $865.5M | $19.4M | ||
| Q1 24 | $793.4M | $8.0M |
| Q4 25 | $2.7B | $570.5M | ||
| Q3 25 | $2.4B | $577.2M | ||
| Q2 25 | $2.6B | $583.9M | ||
| Q1 25 | $2.6B | $590.5M | ||
| Q4 24 | $2.6B | $597.1M | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
| Q4 25 | $3.2B | $865.9M | ||
| Q3 25 | $3.3B | $890.7M | ||
| Q2 25 | $3.2B | $833.8M | ||
| Q1 25 | $3.2B | $789.2M | ||
| Q4 24 | $3.3B | $764.9M | ||
| Q3 24 | $3.3B | $732.5M | ||
| Q2 24 | $3.3B | $706.5M | ||
| Q1 24 | $3.6B | $856.2M |
| Q4 25 | $9.2B | $2.2B | ||
| Q3 25 | $8.9B | $2.2B | ||
| Q2 25 | $8.8B | $2.1B | ||
| Q1 25 | $8.7B | $2.0B | ||
| Q4 24 | $8.8B | $2.2B | ||
| Q3 24 | $8.9B | $2.1B | ||
| Q2 24 | $8.8B | $2.0B | ||
| Q1 24 | $9.0B | $2.2B |
| Q4 25 | 0.83× | 0.66× | ||
| Q3 25 | 0.71× | 0.65× | ||
| Q2 25 | 0.81× | 0.70× | ||
| Q1 25 | 0.82× | 0.75× | ||
| Q4 24 | 0.78× | 0.78× | ||
| Q3 24 | 0.79× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.70× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $256.4M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $254.5M | — |
| FCFマージンFCF / 売上 | 45.7% | — |
| 設備投資強度設備投資 / 売上 | 0.3% | — |
| キャッシュ転換率営業CF / 純利益 | 0.74× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $967.1M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $256.4M | $114.1M | ||
| Q3 25 | $277.1M | $137.3M | ||
| Q2 25 | $230.8M | $137.2M | ||
| Q1 25 | $208.9M | $-117.5M | ||
| Q4 24 | $212.5M | $133.0M | ||
| Q3 24 | $265.2M | $91.8M | ||
| Q2 24 | $245.2M | $107.0M | ||
| Q1 24 | $209.2M | $-125.2M |
| Q4 25 | $254.5M | — | ||
| Q3 25 | $275.9M | — | ||
| Q2 25 | $229.4M | — | ||
| Q1 25 | $207.3M | — | ||
| Q4 24 | $211.4M | — | ||
| Q3 24 | $264.5M | — | ||
| Q2 24 | $244.6M | — | ||
| Q1 24 | $208.2M | — |
| Q4 25 | 45.7% | — | ||
| Q3 25 | 52.3% | — | ||
| Q2 25 | 46.5% | — | ||
| Q1 25 | 41.7% | — | ||
| Q4 24 | 40.3% | — | ||
| Q3 24 | 51.2% | — | ||
| Q2 24 | 48.9% | — | ||
| Q1 24 | 41.6% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 0.74× | 3.39× | ||
| Q3 25 | 1.30× | 1.91× | ||
| Q2 25 | 2.74× | 3.49× | ||
| Q1 25 | 2.89× | -5.66× | ||
| Q4 24 | 1.31× | 4.36× | ||
| Q3 24 | 2.15× | 4.72× | ||
| Q2 24 | 3.23× | — | ||
| Q1 24 | 1.40× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMG
セグメントデータなし
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
